$0.8185
-0.35-30.05%
Last update: Jun 5, 8:09 AM
BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc.
BCLIOTCQB
Market sentiment signals for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (BCLI): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
—
1 analysts
Options Flow (P/C)
—
Avg Consensus PT
—
Highest Price Target
—
Lowest Price Target
—
Short Interest
0.3%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Jul 23, 2025 | Maxim Group | Jason McCarthy— | — | — | Downgrade | Buy→Hold |
| Jul 11, 2024 | Maxim Group | Jason McCarthy— | +3565.5% | $30 | Upgrade | Hold→Buy |
